DirectorAstraZeneca Payer Evidence, United States
Astrazeneca (Employment)
L-2C - The Prevalence of Hyperkalemia and Associated Clinical Characteristics and Outcomes Among Hospitalized COVID-19 Patients
Monday, August 23, 20216:30 PM – 7:30 PM US Eastern Time